USPTO has granted Patent US12590290B2 to Mackay Medical College covering a method for treating hearing loss using a combination of transcription factors to generate hair cell-like cells for cell replacement therapy. The patent application (No. 17052818) was filed on April 30, 2019, and the patent includes 13 claims.

Patent holders should ensure this intellectual property is properly maintained and monitored for potential licensing opportunities or infringement concerns. Third parties interested in using this technology commercially should seek licensing agreements with Mackay Medical College. There is no immediate compliance action required for most entities—this is a patent grant that establishes exclusive rights rather than imposing regulatory obligations.